Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 310.00
-7.00 (-2.21%)
Jun 3, 2026, 3:13 PM JST
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 42.8 billion as of June 2, 2026. Its market cap has increased by 33.06% in one year.
Market Cap
42.80B
Enterprise Value
34.55B
Revenue
74.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
310.00
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 42.80B, a decrease of -36.20%. That is a compound annual growth rate of -4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 42.80B | 35.28% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 141.95B |
| Takara Bio | 137.63B |
| PeptiDream | 135.35B |
| SanBio Company | 100.83B |
| Nxera Pharma | 93.20B |
| Oncolys BioPharma | 68.73B |
| Cuorips | 40.92B |
| Japan Tissue Engineering | 24.69B |